Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice

Ji Pang; Jin-peng Guo; Min Jin; Zhi-qiang Chen; Xin-wei Wang; Jun-wen Li

doi:10.1007/s11655-011-0642-1

Your Location：

Home >

Browse articles >

Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice

OriginalPaper | Updated：2021-08-27

- Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice
- Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice
- 中国结合医学杂志（英文版） 2011年17卷第10期页码：764-769
- Affiliations：
  
  1. Institution of Healthy and Toxicology, Beijing Centers for Disease Prevention and Control,Beijing,China
  2. Disease Prevention and Control Institute of the Chinese People’s Liberation Army,Tianjin,China
  3. Department of Environment and Health, Institute of Environmental and Health,Tianjin,China
- Author bio：
- Funds：
  
  Supported by the National High Technology Research and Development Program of China (863 Program, No. 2006AA06Z408)
- DOI：10.1007/s11655-011-0642-1
  中图分类号：
- 纸质出版日期：2011，
  
  网络出版日期：2013-3-26，
Scan for full text
Pang, J., Guo, Jp., Jin, M. et al. Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice., Chin. J. Integr. Med. 17, 764–769 (2011). https://doi.org/10.1007/s11655-011-0642-1

Ji Pang, Jin-peng Guo, Min Jin, et al. Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice[J]. Chinese Journal of Integrative Medicine, 2011,17(10):764-769.
Pang, J., Guo, Jp., Jin, M. et al. Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice., Chin. J. Integr. Med. 17, 764–769 (2011). https://doi.org/10.1007/s11655-011-0642-1 DOI：

Ji Pang, Jin-peng Guo, Min Jin, et al. Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice[J]. Chinese Journal of Integrative Medicine, 2011,17(10):764-769. DOI： 10.1007/s11655-011-0642-1.

摘要

To investigate the antiviral effects of the aqueous extract of Spatholobus suberectus Dunn. (A.E.)

a Chinese medicinal herb

against coxsackievirus B3 (CVB3). The antiviral effects of A.E. against CVB3 in vitro (primarily cultured myocardial cells) and in vivo (BALB/c mice) were determined. Serum pharmacological method was also adopted by in vitro experiments. The effects of A.E. inhibiting the CVB3 mRNA expression were compared by RT-PCR in mice in vivo. A.E. exhibited obvious antiviral: effects in vivo

and serum samples obtained from the rats with oral administration of A.E. (10 μg/mL

5 μg/mL)

reduced the virus titers in the infected myocardial cells (3.00±0.70

3.55±0.52

P<0.01). Meanwhile

the viral myocarditis induced by CVB3 was inhibited significantly by A.E.

and the 15-day mortality was reduced to 40% and 45% (P<0.01) in mice treated with A.E. at doses of 50 mg/kg and 100 mg/kg

respectively

while the 30-day mortality was decreased to 45% and 50%

respectively (P<0.01). Moreover

the mRNA expression of Coxsackie virus B3 was significantly inhibited by A.E. Aqueous extract of Spatholobus suberectus Dunn. (A.E.) has inhibitory effect on CVB3 both in vitro and in vivo.

Abstract

To investigate the antiviral effects of the aqueous extract of Spatholobus suberectus Dunn. (A.E.)

a Chinese medicinal herb

and serum samples obtained from the rats with oral administration of A.E. (10 μg/mL

5 μg/mL)

reduced the virus titers in the infected myocardial cells (3.00±0.70

3.55±0.52

P<0.01). Meanwhile

the viral myocarditis induced by CVB3 was inhibited significantly by A.E.

and the 15-day mortality was reduced to 40% and 45% (P<0.01) in mice treated with A.E. at doses of 50 mg/kg and 100 mg/kg

respectively

while the 30-day mortality was decreased to 45% and 50%

respectively (P<0.01). Moreover

the mRNA expression of Coxsackie virus B3 was significantly inhibited by A.E. Aqueous extract of Spatholobus suberectus Dunn. (A.E.) has inhibitory effect on CVB3 both in vitro and in vivo.

关键词

aqueous extract of Spatholobus suberectus Dunn.Coxsackievirus B3Viral Myocarditis

Keywords

aqueous extract of Spatholobus suberectus Dunn.Coxsackievirus B3Viral Myocarditis

references

Rajtar B, Majek M, Polanski L, Polz-Dacewicz M. Enteroviruses in water environment—a potential threat to public health. Ann Agric Environ Med 2008;15:199–203.

Gao G, Zhang J, Si X, Wong J, Cheung C, McManus B, Luo H. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice. Am J Physiol Heart Circ Physiol 2008;295:H401–H408.

Liu XJ, Li W, Zhang YQ, Liu YM, Liu LZ. Clinical features and treatment of serious brainstem encephalitis caused by enterovirus 71 infection. Chin J Contemp Pediatr (Chin) 2009;11:967–969.

Huang KC, ed. The pharmacology of Chinese herbs. Boca Raton: CRC Press; 1993:261.

Li RW, Lin GD, Myers SP, Leach DN. Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol 2003;5:61–67.

Goda Y, Shibaya M, Sankawa U, Yukihiro G. Inhibitors of prostaglandin biosynthesis from Mucuna birdwoodiana. Chem Pharm Bull 1987;35:2675–2677.

Yuan WL, Chen HZ, Yang YZ, Yang XY, Lin YS, Jin PY, et al. Effect of Astragalus membranaceus on electric activities of cultured rat beating heart cells infected with CVB-3 virus. Chin Med J 1990;103:177–182.

Bishop JM, Koch G. Plaque assay for poliovirus and poliovirus specific RNAs. In: Habel, K, Salzman NP, eds. Fundamental techniques in virology. New York: Academic Press; 1969:131–145.

Zhang YY, Zhu H, Ye G, Huang CG, Yang YZ, Chen RZ, et al. Antiviral effects of sophoridine against coxsackievirus B3 and its pharmacokinetics in rats. Life Sci 2006;78:1998–2005.

Severini GM, Mestroni L, Falaschia A, Camerini F, Giacca M. Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples. J Clin Micorobiol 1993;31:1345–1349.

Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH, Boyd MR. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 1989;81:577–586.

Huang L, Gu Y, Li H. Advances in herbal volatile oil and aromatic herbs. Chin J Chin Mater Med (Chin) 2009;34:1605–1611.

Melnick JL. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: David MK, Peter MH, eds. Fields virology. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1996:655–712.

Chow LH, Beisel KW, McManus BM. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 1992;66:24–31.

Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovas Res 2003;60:5–10.

Zhang Y, Simpson AA, Ledford RM, Bator CM, Chakravarty S, Skochko GA, et al. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J Virol 2004;78:11061–11069.

Yuan J, Stein DA, Lim T, Qiu D, Coughlin S, Liu Z, et al. Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site. J Virol 2006;80:11510–11519.

Han J, Zhao YL, Shan LM, Huang FJ, Xiao XH. An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replication in vitro. Chin J Integr Med 2005;11:54–56.

FULL TEXT LINK

More>

浏览量

817

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Astragalus membranaceus Injection combined with conventional treatment for viral myocarditis: A systematic review of randomized controlled trials

Effects of Yiqi Huoxue Recipe (益气活血方) and Coxsackie virus B type 3 on the expression of ribosomal protein S20 in rat cardiac myocytes

Observation on therapeutic effects of Shengmai powder in treating acute viral myocarditis

Effect of Astragalus Injection on levels of blood selenium and immunity function in children with viral myocarditis

Effect of prevention and treatment of murine acute viral myocarditis and protection of lymphoid organ atrophy with xinkang oral liquid